Systemic release of high mobility group box 1 protein during severe murine influenza
- PMID: 18606700
- DOI: 10.4049/jimmunol.181.2.1454
Systemic release of high mobility group box 1 protein during severe murine influenza
Abstract
Hypercytokinemia is gaining recognition as the mechanism of fatality from influenza. No work to date has addressed the role of high mobility group box 1 protein (HMGB1) in influenza, the parallel being that in other severe proinflammatory cytokine syndromes (e.g., sepsis and malaria) levels of circulating HMGB1 are elevated and may correlate with death. Using a commercially available ELISA for HMGB1, we found that HMGB1 was not increased in the plasma of influenza virus-infected mice (A/Japan/305/57) on day 7 post infection, about the time of peak mortality, and peak levels of HMGB1 in the plasma did not occur until relatively late in infection, on day 9 post infection. In keeping with the late peak of HMGB1 being unassociated with mortality, administration of ethyl pyruvate, which inhibits active secretion but not passive release of HMGB1, to influenza virus-infected mice, did not affect their survival. Further work is required to determine whether influenza virus infection induces passive release of HMGB1, and whether HMGB1 neutralization with a specific Ab would improve survival.
Similar articles
-
Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections.mBio. 2018 Mar 13;9(2):e00246-18. doi: 10.1128/mBio.00246-18. mBio. 2018. PMID: 29535197 Free PMC article.
-
Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide.J Med Virol. 2018 Jul;90(7):1192-1198. doi: 10.1002/jmv.25076. Epub 2018 Mar 31. J Med Virol. 2018. PMID: 29573352
-
Potential role of high-mobility group box 1 protein in the pathogenesis of influenza H5N1 virus infection.Acta Virol. 2014;58(1):69-75. doi: 10.4149/av_2014_01_69. Acta Virol. 2014. PMID: 24717031
-
DAMPs and influenza virus infection in ageing.Ageing Res Rev. 2015 Nov;24(Pt A):83-97. doi: 10.1016/j.arr.2015.07.005. Epub 2015 Jul 19. Ageing Res Rev. 2015. PMID: 26200296 Review.
-
High-Mobility Group Box-1 and Its Potential Role in Perioperative Neurocognitive Disorders.Cells. 2021 Sep 28;10(10):2582. doi: 10.3390/cells10102582. Cells. 2021. PMID: 34685561 Free PMC article. Review.
Cited by
-
Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic.Pharmacol Res Perspect. 2022 Apr;10(2):e00926. doi: 10.1002/prp2.926. Pharmacol Res Perspect. 2022. PMID: 35174650 Free PMC article. Review.
-
Leukocyte-Derived High-Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes.Hepatol Commun. 2021 Dec;5(12):2104-2120. doi: 10.1002/hep4.1777. Epub 2021 Jul 28. Hepatol Commun. 2021. PMID: 34558858 Free PMC article.
-
[The mechanism and treatment strategies of SARS-CoV-2 mediated inflammatory response].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020 Aug 25;37(4):572-578. doi: 10.7507/1001-5515.202003030. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020. PMID: 32840072 Free PMC article. Chinese.
-
Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review.Int J Mol Sci. 2020 Jun 30;21(13):4639. doi: 10.3390/ijms21134639. Int J Mol Sci. 2020. PMID: 32629817 Free PMC article. Review.
-
[HMGB1: a link between innate and adaptive immunity].Rev Francoph Lab. 2009 Dec;2009(417):59-68. doi: 10.1016/S1773-035X(09)70310-7. Epub 2009 Dec 11. Rev Francoph Lab. 2009. PMID: 32288806 Free PMC article. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases